Drugs / Allegra-D
last change Aug 2008 re-read 2 minutes ago

Allegra-D

Developed for
allergic rhinitis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00562120 Comparator Dec 2007 → Aug 2008 allergic rhinitis Pfizer Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Allegra-D ClinicalTrials.gov intervention name — accepted as the source's own label NCT00562120
Route Oral “A single oral dose of Allegra-D is dosed to subjects” NCT00562120